Turpaz: Is Specialty Fine Ingredients Really Back On Track

The main article argued that Turpaz entered 2025 with a growth engine that still works, but also with a balance sheet already carrying the cost of acquisitions. This follow-up isolates only one part of that engine, Specialty Fine Ingredients. It was the segment with the fastest organic growth in the group in 2025, 65.6%, but it was also the segment with the noisiest profitability base.

If you look only at revenue, it is easy to conclude that the business is already back on track. That is too superficial. Once you look at margin, war compensation, product-mix change, and the dependence on the Nir Yitzhak site, the picture becomes more nuanced: demand has recovered, but profitability is still not clean. The recovery rests on returning customers, new products, process improvement, and activity at a site that is still moving through operational and environmental normalization.

Three points stand out immediately from the selected materials. First: the demand base genuinely improved, otherwise it is hard to explain 65.6% organic growth for the full year and 26.5% organic growth in the fourth quarter. Second: the margin comparison between 2024 and 2025 is still distorted by war compensation, so the reported number alone does not tell you whether the segment is truly "back." Third: even after customers returned, the bottleneck did not disappear. It shifted from the market to the Nir Yitzhak site, to its environmental systems, and to the segment's ability to turn growth into cleaner profitability.

Demand Came Back, The Margin Hasn't Yet

On a full-year view, the segment looks like a sharp recovery story. Revenue rose to $31.0 million from $18.5 million, organic growth reached 65.6%, and operating profit increased to $3.65 million from $3.05 million. But the very line that should confirm a clean return contains the contradiction: the operating margin fell to 11.8% from 16.5%.

That is not a random contradiction. The company explicitly says that the annual margin change was driven mainly by state compensation related to the war, about $2.8 million in 2024 versus about $1.3 million in 2025. In other words, a large part of the reported margin decline reflects the fact that the base year contained a thicker compensation layer. The annual comparison is therefore not clean. If you look roughly at operating profit after stripping out that compensation, the segment's profit base in 2025 appears materially stronger than it was in 2024.

But it would be a mistake to jump from there to the opposite conclusion and say the problem is solved. The fourth quarter shows that the segment still has not returned to a clean margin profile. Revenue in Q4 2025 rose to $7.0 million from $5.3 million, with organic growth of 26.5%, but operating profit fell to $0.69 million from $1.52 million, and margin dropped to 9.8% from 28.5%.

That is the core point. 2025 proved that the segment knows how to get back to growth. It did not yet prove that this growth is already translating into a stable, clean, and readable margin structure. Anyone reading the annual improvement without checking the exit quarter is at risk of mistaking a transition process for a fully normalized recovery.

What Actually Drove The Recovery

The filing does not describe a passive return to normal, as if customers simply came back and everything fell into place. It describes a more deliberate repositioning. The segment's 2025 organic growth was attributed to product-mix change, a focus on and introduction of aromatic chemicals and citrus products for the taste and fragrance industries, improved operating processes, and new-product launches. At the same time, the report explicitly points to a trend of customers returning to the Kimyda plant starting in Q4 2024, with that trend strengthening from Q1 2025.

The most important detail is that demand recovery did not arrive on its own. It arrived together with a commercial shift inside the segment. So the right question is not simply whether customers returned. The real question is what kind of product basket they returned to, and at what margin. The more growth rests on aromatic chemicals and citrus products for the taste and fragrance industries, the more the segment becomes tied to Turpaz's core taste and fragrance engine and the less it depends on recreating the exact historical mix. That is positive, but it also means a simple comparison to old margins can miss the real story.

This is also where management's own wording matters. The company says the actions it took are expected to contribute to margin improvement in coming quarters. That is an important admission, because it implies that the improvement had not fully flowed through the numbers by the end of 2025. This is still a reset year, not yet a full proof year.

The Bottleneck Still Sits At Nir Yitzhak

The 2025 recovery increases the importance of the Nir Yitzhak site rather than reducing it. The plant, which is the center of gravity for the segment in Israel, runs 7 days a week in three shifts. The company says it still has about 40% additional production potential through investment in tooling and better use of the existing site footprint, and it also has a production setup in Romania that can support capacity in line with customer demand. That is the encouraging side of the story: there is no immediate physical wall.

But that does not remove the bottleneck. The same filing explicitly describes a certain dependence on the Nir Yitzhak site in Specialty Fine Ingredients and warns that damage to the site or a shutdown could reduce or even stop the activity in that segment. That matters because in taste and fragrance the group describes greater flexibility to shift production between plants in different countries, while in Specialty Fine Ingredients that flexibility is clearly weaker. Romania is a support layer. It does not eliminate Nir Yitzhak as the operational center of gravity.

The environmental layer is not sitting at the margin of the story either. In Specialty Fine Ingredients, and especially in bromine-based products, the group itself describes tighter operational and environmental regulation. The business license for Nir Yitzhak includes additional conditions related to hazardous materials, waste, odor, noise, wastewater, and air emissions. The site's emissions permit is valid until July 2030, but in order to comply with it the company needs an RTO emissions-treatment system.

The company has already invested and signed with an international supplier to build that system, at an investment of about $2.9 million, most of which has already been spent. The equipment arrived on site in April 2024, but because of the war and the site's proximity to Gaza, the supplier had still not come to install it. Installation is expected, according to the filing, during the first half of 2026. The business meaning is not only environmental. Commercial recovery started before the site completed its operational and regulatory normalization work. That is why the end of 2025 is still a transition point rather than a settled base.

There is also an investment layer that reinforces the point. The company still has an approved investment program from 2020 to expand the Kimyda plant at Nir Yitzhak, at about NIS 11 million, with execution running through December 30, 2026, while most of the investment has already been carried out. In addition, a second program was approved in December 2024 to preserve business activity in the Tekuma region, at about NIS 12.6 million, with a 50% grant and a deadline at the end of September 2027. In other words, the site is not in simple maintenance mode. It is still inside a sequence of investment, adjustment, and capability-building.

That also explains why the environmental survey the group conducted during the year did not identify environmental or climate risks as material to the group as a whole, while at the same time Specialty Fine Ingredients was described as the business line with higher environmental and regulatory complexity. There is no immediate existential threat to the group here, but there is clearly an operating focus area that still needs completion and proof.

What Has To Happen Next To Call This A Real Return

Checkpoint one: margin has to improve without compensation support. After two years of war compensation, the real test is whether the segment can produce higher-margin quarters once that noise disappears.

Checkpoint two: returning customers have to become a stable order base, not just a correction after a temporary shift to alternative suppliers. The filing already gives a clear positive signal, but it does not yet prove that the new base is fully settled.

Checkpoint three: Nir Yitzhak has to finish the transition phase. Installing the RTO system in the first half of 2026, continuing the capacity build-out, and managing the site without new war-related disruption are part of the route from commercial recovery to cleaner profitability.

That leads to the main conclusion of this follow-up. Specialty Fine Ingredients is not "back on track" in the simple sense of returning to the old business with the old margin. It is moving onto a new track, with more aromatic chemicals and citrus products, more linkage to the taste and fragrance industries, more process improvement, and more dependence on the ability to finish normalizing the Nir Yitzhak site. That may well be the better track. It is simply not finished yet.

Conclusion

Turpaz ended 2025 with a real recovery in Specialty Fine Ingredients, but not with full proof that margin has already come back. The 65.6% organic growth and the return of customers to Kimyda are clearly positive. The annual margin decline to 11.8% is misleading if read without the war-compensation effect. On the other hand, the fourth-quarter margin of 9.8% is a clear reminder that the segment had not yet fully exited the transition period.

Current thesis: demand and execution have improved for real, but profitability still rests on a transition base that includes lower compensation, a new product mix, and a key site that is still completing normalization work.

What changed versus the broader read: in the main article it was enough to say that Turpaz's operating engine still works. Here the picture is sharper. The engine in this segment works, but the transmission still has not fully settled.

Counter-thesis: one can argue that the end of 2025 simply does not represent the true margin base, because the company has already brought customers back, changed mix, and completed efficiency moves that should lift profitability in coming quarters.

What could change the market reading in the short to medium term: installing the RTO system on time, showing stronger margins without compensation support, and proving that the return to Kimyda is turning into repeat business rather than just gap-filling.

Why this matters: if this segment truly stabilizes, it can move from being the noisiest comparison set in the group to being a cleaner profit engine. If it does not, Turpaz will keep showing growth here that looks stronger on paper than the profitability it is actually producing.